Skip to content

Blood Pressure Control in ESH Excellence Centres

Study of the European Society of Hypertension on Blood Pressure Control in ESH Excellence Centres

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04295434
Acronym
BP-CON
Enrollment
3000
Registered
2020-03-04
Start date
2018-10-01
Completion date
2021-03-01
Last updated
2020-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure, Lifestyle Risk Reduction, White Coat Hypertension

Keywords

Blood pressure, Hypertension, Control, European, Excellence centres

Brief summary

In the BP-CON-ESH study we are going to include and analyze treated hypertensive patients seen consecutively by the ESH Excellence Centres. Blood pressure will be measured as usually done in the office, but care will be adopted to make measurements highly standardized in all Centres. The primary goals will be to determine the global, regional and country rates of hypertension control in Europe. Other goals will be to identify global and regional factors associated with blood pressure control in different European regions. The results obtained in the BP-CON-ESH project will be used to refine treatment strategies for improvement of blood pressure control and will serve as a basis for assessing future changes and trends in Europe.

Detailed description

The most important task of the European Society of Hypertension is to improve blood pressure treatment and increase blood pressure control, thus decreasing cardiovascular risk, premature cardiovascular and renal morbidity and mortality, with in addition a reduction of health-care costs. More than a decade ago, the European Society of Hypertension established a network of Excellence Centres. Those centres are leading institutions for the diagnosis and treatment of hypertension and thus are front runners of good clinical practice in hypertension management in their countries. An important task of the Excellence Centres is also to be active in research, particularly in projects conducted by the European Society of Hypertension. The ongoing BP-CON-ESH project on the rate of blood pressure control in hypertensive patients addresses the most elementary,but at the same timethe most important aspect in hypertension management, because the observed low rates of blood pressure control is the reason why hypertension is still today the leading cause of death worldwide. In the BP-CON-ESH study we are going to include and analyze treated hypertensive patients seen consecutively by the ESH Excellence Centres. Blood pressure will be measured as usually done in the office, but care will be adopted to make measurements highly standardized in all Centres. The primary goals will be to determine the global, regional and country rates of hypertension control in Europe. Other goals will be to identify global and regional factors associated with blood pressure control in different European regions. It is well known that the overall control of hypertension in Europe is still insufficient. However, the problem is not the same across Europe. Differences in healthcare systems exist among European countries, and in some countries government healthcare system only partially reimburse costs of antihypertensive therapy. There are also differences in gross national product, educational levels, salt consumption, prevalence of obesity and other aspects. These could cause dissimilarities in hypertension prevalence, achieved blood pressure control and cardiovascular mortality among European regions. The results obtained in the BP-CON-ESH project will be used to refine treatment strategies for improvement of blood pressure control and will serve as a basis for assessing future changes and trends in Europe.

Interventions

None listed

Sponsors

European Society of Hypertension
CollaboratorOTHER
Clinical Hospital Centre Zagreb
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Signed informed consent

Exclusion criteria

* Pregnancy and breastfeeding * Terminal malignancy, reduced life expectancy (\<6 months) * Amputated limb * Dementia * Patients living in a nursing home * Unsigned informed consent

Design outcomes

Primary

MeasureTime frameDescription
Blood pressure controlThrough study completion, an average of 1 yearDifference in blood pressure values between ESH Excellence Centres

Countries

Armenia, Austria, Belgium, Bulgaria, Croatia, Czechia, Estonia, Germany, Greece, Israel, Italy, Lebanon, Lithuania, Netherlands, Poland, Portugal, Romania, Serbia, Spain, Sweden, Ukraine, United Kingdom

Contacts

Primary ContactBojan Jelaković, MD, PhD
jelakovicbojan@gmail.com00385959030751
Backup ContactBranimir Krtalić, MD
bkrtalic@gmail.com00385923314348

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026